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To the Editor :
We read with great interest the article by Guyot-Revol and
colleagues (1) assessing the role of T regulatory cells (Tregs)
in tuberculosis (TB) pathogenesis. Guyot-Revol and coworkers
found that in patients with TB, percentages of CD4CD25high
T cells and levels of FoxP3 mRNA expression in peripheral
blood mononuclear cells were both signiﬁcantly higher in com-
parison with controls. To better comprehend Tregs’ mechanism
of action, the authors investigated whether the increased levels
of FoxP3 mRNA that they had observed were effectively caused
by increased gene expression, or were simply the result of in-
creasedCD4CD25high frequency.FoxP3mRNAinCD4CD25
T cells was compared between patients with TB and control sub-
jects. As no quantitative difference was observed, the authors
suggest that the greater levels of FoxP3 mRNA are simply an
effect of increases in Treg frequency rather than a result of an
up-regulated gene expression.
The transcription factor FoxP3 is the most speciﬁc molecular
marker for Tregs available to date, and its correct evaluation is
crucial (2–4). In the analysis of Treg dynamics, an assessment
of what happens in the frequency and level of FoxP3 mRNA
expression at the single cell level is mandatory. The recent litera-
ture demonstrates a strong correlation between levels of CD25
expression and the frequency of FoxP3-positive cells in healthy
donors (4), and suggests that to correctly evaluate FoxP3 expres-
sion in Tregs, mRNA should be quantiﬁed in CD4CD25high,
rather than in CD4CD25 T cells (5).
We are currently performing a prospective study to evaluate
Tregs in patients with TB. Analysis of CD4CD25high percentage
on CD4 T cells at TB diagnosis showed similar levels of Tregs
among patients with TB and controls (median percentage: 2.1%
[IQR, 1.8–6.6] vs. 1.9% [IQR, 1.5–2.2]). Unlike Guyot-Revol and
coworkers, we evaluated FoxP3 mRNA expression by real-time
polymerase chain reaction in CD4CD25high T cells, puriﬁed using
an EPICSALTRACell Sorter (Beckman-Coulter; purity 93.6%).
A considerable increase of FoxP3 mRNA expression in patients
with TB with respect to control subjects was clearly observed
(median: 39.1 [IQR, 5.1–109] vs. 1.6 [IQR, 0.8–2.8]; p  0.0062).
These data implicate FoxP3 gene overexpression as a probable
mechanism involving Tregs in the pathogenesis of TB, and sug-
gest a possible role of FoxP3 gene up-regulation in the outcome
of chronic infections.
Our results underscore the importance of using the correct
methodology in evaluating Treg cell dynamics, and prove that
an accurate evaluation of FoxP3 mRNA expression in Treg cells
may lead to the identiﬁcation of previously unknown mecha-
nisms of Treg cell involvement in disease pathogenesis.
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From the Authors :
We thank Gazzola and colleagues for their interest in our recent
article, the ﬁrst to describe a role for regulatory T cells (Tregs)
in tuberculosis (1).Ourmain ﬁndingwas an increased percentage
of CD4CD25high T cells in the CD4 T-cell fraction of periph-
eral blood mononuclear cells (PBMCs), and increased FoxP3
mRNA expression in PBMCs in patients with tuberculosis com-
pared with healthy control subjects. In contrast, Gazzola and
coworkers’ interim results from their ongoing study (as men-
tioned in their letter) show no increase in CD4CD25high T
cells in patients with tuberculosis compared with healthy control
subjects, and they seem not to have measured FoxP3 expression
in PBMCs. The median proportion of CD4CD25high T cells in
their healthy controls (1.9%) was not dissimilar to ours (1.17%),
suggesting that our gating was comparable.
Whenwe comparedFoxP3mRNAexpression inCD4CD25
T cells in patients and controls, we found no signiﬁcant differ-
ence, suggesting that the increased FoxP3 expression in tubercu-
losis reﬂects increased frequencies of Tregs rather than increased
expression of FoxP3 per cell. Gazzola and coworkers compared
FoxP3 expression in CD4CD25high T cells and found a 24-fold
increase in patients with tuberculosis. In general, CD4CD25
T cells constitute about 5–10% of CD4 T cells, whereas
CD4CD25high T cells constitute about 1–2%. Therefore, if
CD4CD25high T cells in our patients with tuberculosis were
expressing 24 times more FoxP3 than in our controls, we should
have observed an approximate four- or ﬁvefold increase inFoxP3
expression in the CD4CD25 T-cell fraction, 20% of which
was composed of CD4CD25high T cells. The fact that we did not
see such a difference is at variance with Gazzola and coworkers’
observation. Thus, two of Gazzola and coworkers’ ﬁndings are
in contrast to our own for unclear reasons. However, we are not
